BioSpace News Archive

Drug Development

Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR

Milestone Pharmaceuticals Inc. announced that the Company will host a virtual investor and analyst webcast on Monday, November 13, 2023 at 8:00 a.m. ET.

November 7, 2023
·
6 min read
Business

Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates

Fusion Pharmaceuticals Inc. announced financial results for the third quarter ended September 30, 2023 and provided an update on clinical and corporate developments.

November 7, 2023
·
12 min read
Genetown

Remix Therapeutics Announces Participation in Jefferies 2023 London Healthcare Conference

Remix Therapeutics, a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, announced that the Company will be participating in the Jefferies London Healthcare Conference taking place November 14-16, 2023.

November 7, 2023
·
1 min read
BioCapital

REGENXBIO to Participate in Upcoming November 2023 Investor Conferences

REGENXBIO Inc. announced it will participate the following upcoming investor conferences.

November 7, 2023
·
1 min read
Pharm Country

Marinus Pharmaceuticals Initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

Marinus Pharmaceuticals, Inc. announced the initiation of the Marinus Access Program, a global managed access program for ZTALMY® oral suspension CV.

November 7, 2023
·
10 min read
Genetown

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences - November 7, 2023

Deciphera Pharmaceuticals, Inc. today announced that members of the management team will participate in fireside chats at the following investor conferences.

November 7, 2023
·
1 min read
Pharm Country

Arbutus Announces CEO, William Collier, to Retire December 31, 2023

Arbutus Biopharma Corporation announced that William Collier will retire from his position as the Company’s President and Chief Executive Officer, and as a member of the Board of Directors, at the end of 2023.

November 7, 2023
·
7 min read
Pharm Country

Henry Schein to Present at Upcoming Investor Conferences in November 2023

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced that the Company will present at the following investor conferences.

November 7, 2023
·
2 min read
Policy

Alucent Biomedical Receives Regulatory Approval for Second U.S. Clinical Study

Alucent Biomedical Inc. announced that the U.S. Food & Drug Administration granted an Investigational Device Exemption for a U.S. clinical study of its AlucentNVS technology for promoting the maturation of arteriovenous fistulas in patients requiring hemodialysis.

November 7, 2023
·
2 min read
Pharm Country

Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docetaxel Formulation in a Melanoma Model

Matinas BioPharma Holdings, Inc. announces positive results from an in vivo animal study of an oral LNC formulation of docetaxel, a well-known chemotherapeutic agent used in the management of multiple metastatic and unresectable tumors.

November 7, 2023
·
6 min read